Active ingredient and composition:
Each 5 ml of the reconstituted suspension contains:
Cefuroxime Axetil USP equivalent to Anhydrous Cefuroxime 125 mg.
Excipients: betacyclodextrin, purified water, isopropyl alcohol, sucrose, xanthan gum, aspartame, acesulfame–K Pharma D, purified talc, tutti frutti premium flavour.
CEFUROXIZEN DS powder for oral suspension is indicated for the treatment of pediatric patients from 3 months to 12 years of age with mild to moderate infections caused by susceptible strains of the designated microorganisms in the following conditions: Pharyngitis/Tonsillitis: the usual drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever, is penicillin given by the intramuscular route. CEFUROXIZEN DS powder for oral suspension is generally effective in the eradication of streptococci from the nasopharynx. Acute bacterial otitis media. Impetigo.
CEFUROXIZEN-DS is contraindicated in patients with known allergy to the cephalosporin group of antibiotics.
CEFUROXIZEN-DS is available as 125mg / 5ml Cefuroxime oral suspension (as Cefuroxime Axetil) in 30ml bottles. Possibility to adapt packing and quantities to customer needs.